LOC389333 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.071400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.877580E-01
Normal-vs-Stage2
1.889450E-01
Normal-vs-Stage3
8.655200E-01
Normal-vs-Stage4
1.771630E-01
Stage1-vs-Stage2
8.428800E-01
Stage1-vs-Stage3
2.774400E-01
Stage1-vs-Stage4
5.599600E-01
Stage2-vs-Stage3
1.977220E-01
Stage2-vs-Stage4
6.313800E-01
Stage3-vs-Stage4
4.973000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.065800E-01
Normal-vs-AfricanAmerican
2.940000E-01
Normal-vs-Asian
1.694950E-01
Caucasian-vs-AfricanAmerican
4.989000E-01
Caucasian-vs-Asian
2.328000E-01
AfricanAmerican-vs-Asian
2.597800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.215200E-01
Normal-vs-Female
1.913000E-01
Male-vs-Female
5.364800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.154350E-01
Normal-vs-Age(41-60Yrs)
8.094200E-02
Normal-vs-Age(61-80Yrs)
2.974000E-01
Normal-vs-Age(81-100Yrs)
3.613000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.419400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.907600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.674580E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.767900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.618030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.206200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.519380E-01
Normal-vs-Daily Drinker
3.764800E-01
Normal-vs-Weekly Drinker
1.292020E-01
Normal-vs-Occasional Drinker
2.674200E-01
Normal-vs-Social Drinker
1.309150E-01
Non Drinker-vs-Daily Drinker
8.499800E-02
Non Drinker-vs-Weekly Drinker
5.606800E-01
Non Drinker-vs-Occasional Drinker
1.352250E-01
Non Drinker-vs-Social Drinker
6.380200E-01
Daily Drinker-vs-Weekly Drinker
4.585800E-02
Daily Drinker-vs-Occasional Drinker
8.458800E-01
Daily Drinker-vs-Social Drinker
5.347700E-02
Weekly Drinker-vs-Occasional Drinker
6.642400E-02
Weekly Drinker-vs-Social Drinker
9.160600E-01
Occasional Drinker-vs-Social Drinker
7.745800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.844600E-01
Normal-vs-Grade 2
8.971000E-01
Normal-vs-Grade 3
9.468600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.698400E-02
Grade 1-vs-Grade 3
1.569540E-02
Grade 1-vs-Grade 4
7.844600E-01
Grade 2-vs-Grade 3
3.046400E-01
Grade 2-vs-Grade 4
8.971000E-01
Grade 3-vs-Grade 4
9.468600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.084400E-01
Normal-vs-NonDiabetic
1.511360E-01
Diabetic-vs-NonDiabetic
3.222400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.776500E-02
Normal-vs-NoPancreatitis
2.099800E-01
Pancreatitis-vs-NoPancreatitis
1.874840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.958580E-01
Normal-vs-N1
2.279000E-01
N0-vs-N1
9.573400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.987600E-01
Normal-vs-TP53-NonMutant
2.465800E-01
TP53-Mutant-vs-TP53-NonMutant
8.296600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
